Lovastatin | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Lovastatin
USP

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

Contact Supplier

Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

xyz-pharma-m-2025-01-06

Contact Supplier

Lovastatin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 30 USDMF, 12 CEP/COS, 1 JDMF, 5 EU WC, 2 KDMF, 9 NDC API, 9 Listed Suppliers, $ API Reference Price

39 API Suppliers
30 USDMF
12 CEP/COS
1 JDMF
5 EU WC
2 KDMF
9 NDC API
9 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

91 FDF Dossiers, 37 FDA Orange Book, 42 Europe, 4 Canada, 2 South Africa, 6 Listed Dossiers

91 FDF Dossiers
37 FDA Orange Book
42 Europe
4 Canada
2 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 20MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 40MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 20MG, TABLET, EXTENDED RELEASE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 60MG

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 20MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 40MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 20MG
TABLET, EXTENDED RELEASE;ORAL - 40MG
TABLET, EXTENDED RELEASE;ORAL - 60MG

RELATED EXCIPIENT COMPANIES

1 Evonik, 4 SPI Pharma, 2 Seqens, 4 DKSH, 5 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 29 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 35 Direct Compression, 31 Controlled & Modified Release, 27 Thickeners and Stabilizers, 25 Solubilizers, 24 Granulation, 20 Disintegrants & Superdisintegrants, 19 Lubricants & Glidants, 18 Topical, 18 Film Formers & Plasticizers, 18 Co-Processed Excipients, 16 Parenteral, 10 Taste Masking, 9 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

70 Fillers, Diluents & Binders
52 Coating Systems & Additives
35 Direct Compression
31 Controlled & Modified Release
27 Thickeners and Stabilizers
25 Solubilizers
24 Granulation
20 Disintegrants & Superdisintegrants
19 Lubricants & Glidants
18 Topical
18 Film Formers & Plasticizers
18 Co-Processed Excipients
16 Parenteral
10 Taste Masking
9 Emulsifying Agents
6 Chewable & Orodispersible Aids
5 Empty Capsules
5 API Stability Enhancers
5 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 7 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
7 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 52 Finished Drug Prices

2 US Medicaid Prescriptions
52 Finished Drug Prices

MARKET PLACE

5 APIs

5 APIs

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 7 Others

2 EDQM
4 USP
7 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 54 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

4 All

01 11236833

02 11370600

03 11370611

04 11370655

filter Description Reset all filters

4 All

01 1Lovastatin (125 mg)

02 1Lovastatin Epimer Mixture (25 mg) (Epilovastatin and Lovastatin 1:1 Mixture)

03 1Lovastatin Impurity Identification Mixture (30 mg)

04 1Lovastatin Related Compound A (20 mg) (4,4a-Dihydrolovastatin)

filter CAS Number Reset all filters

4 All

01 175330-75-5

02 3N/A

Product Main Page

01

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Lovastatin Impurity Identification Mixture (3...

CAS Number : N/A

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1370655

Current Lot : F002Q0

Previous Lot :

NDC Code :

Product Web Link

Digital Content

02

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Lovastatin (125 mg)

CAS Number : 75330-75-5

Quantity Per Vial :

Price ($) : 185

Catalog Number : 1370600

Current Lot : H5K027

Previous Lot : H4K027 (30-APR-2016)

NDC Code :

Product Web Link

Digital Content

03

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Lovastatin Related Compound A (20 mg) (4,4a-D...

CAS Number : N/A

Quantity Per Vial :

Price ($) : 775

Catalog Number : 1370611

Current Lot : R052X0

Previous Lot : J1J060 (30-NOV-2017)

NDC Code :

Product Web Link

Digital Content

04

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Lovastatin Epimer Mixture (25 mg) (Epilovasta...

CAS Number : N/A

Quantity Per Vial :

Price ($) : 760

Catalog Number : 1236833

Current Lot : F006A0

Previous Lot :

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?